GB9704498D0 - Chemical compound - Google Patents
Chemical compoundInfo
- Publication number
- GB9704498D0 GB9704498D0 GBGB9704498.6A GB9704498A GB9704498D0 GB 9704498 D0 GB9704498 D0 GB 9704498D0 GB 9704498 A GB9704498 A GB 9704498A GB 9704498 D0 GB9704498 D0 GB 9704498D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemical compound
- chemical
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
TR1999/02117T TR199902117T2 (xx) | 1997-03-05 | 1998-03-03 | (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu. |
NZ337315A NZ337315A (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid and it's use in the treatment of pain |
CO98011404A CO4940415A1 (es) | 1997-03-05 | 1998-03-03 | Compuesto quimico |
IL13148998A IL131489A0 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylphyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
HU0002109A HUP0002109A2 (hu) | 1997-03-05 | 1998-03-03 | (E)-4,6-diklór-3-(2-oxo-1-fenilpirrolidin-3-ilidén-metil)-1H-indol-2-karbonsav kristályos hidratált nátriumsója, eljárás előállítására és az ilyen vegyületet tartalmazó gyógyszerkészítmény |
EA199900710A EA199900710A1 (ru) | 1997-03-05 | 1998-03-03 | Кристаллическая гидратированная натриевая соль (е)-4,6-дихлор-3-(2-оксо-1-фенилпирролидин-3-илиденметил)-1н-индол-2-карбоновой кислоты |
PE1998000149A PE51399A1 (es) | 1997-03-05 | 1998-03-03 | Forma hidratada cristalina de la sal de sodio del acido (e)-4,6-dicloro-3-(2-oxo-1-fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico |
PL98335652A PL335652A1 (en) | 1997-03-05 | 1998-03-03 | Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid |
IDW990976A ID24207A (id) | 1997-03-05 | 1998-03-03 | Garam natrium yang dihiratkan kristalin dari asam (e) -4,6-dikloro-3-(2-okso-1-enilpirolidin-3-ilidena metil)-1-h-indola-2-karboksilat |
BR9808305-8A BR9808305A (pt) | 1997-03-05 | 1998-03-03 | Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor. |
PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
AU68251/98A AU6825198A (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
JP53813598A JP2001513796A (ja) | 1997-03-05 | 1998-03-03 | (e)−4,6−ジクロロ−3−(2−オキソ−1−フェニルピロリジン−3−イリデンメチル)−1h−インドール−2−カルボン酸の結晶性ナトリウム塩水和物 |
EP98913613A EP0966463A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
SK1196-99A SK119699A3 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo- -1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
KR1019997007987A KR20000075907A (ko) | 1997-03-05 | 1998-03-03 | (e)-4,6-디클로로-3-(2-옥소-1-페닐피롤리딘-3-일리덴 메틸)-1h-인돌-2-카르복실산의 결정질 수화 나트륨염 |
ZA9801791A ZA981791B (en) | 1997-03-05 | 1998-03-03 | Chemical compound. |
EEP199900387A EE9900387A (et) | 1997-03-05 | 1998-03-03 | (E)-4,6-dikloro-3-(2-okso-1-fenüülpürrolidiin-3-ülideenmetüül)-1H-indool-2-karboksü ülhappe naatriumisoola kristallhüdraat |
YU43499A YU43499A (sh) | 1997-03-05 | 1998-03-03 | Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline |
ARP980100948A AR011178A1 (es) | 1997-03-05 | 1998-03-03 | Compuesto de sal de sodio de (acido (e) 4,6-dicloro-3-(2-oxo-1- fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico en su forma hidratada,proceso para su preparacion, composicion farmaceutica que lo contiene y metodo de tratamiento utilizando dicho compuesto |
CN98803053A CN1249750A (zh) | 1997-03-05 | 1998-03-03 | (e)-4,6-二氯-3-(2-氧代-1-苯基吡咯烷-3-亚基甲基)-1h-吲哚-2-甲酸的结晶水合钠盐) |
APAP/P/1999/001637A AP9901637A0 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid. |
CA002282851A CA2282851A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
HR9704498.6A HRP980114A2 (en) | 1997-03-05 | 1998-03-04 | Chemical compound |
IS5166A IS5166A (is) | 1997-03-05 | 1999-08-27 | Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru |
OA9900201A OA11154A (en) | 1997-03-05 | 1999-09-02 | Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid |
NO994303A NO994303L (no) | 1997-03-05 | 1999-09-03 | Krystallinsk hydrert natriumsalt av (E)-4,6-diklor-3-(2-okso-1-fenylpyrrolidin-3-ylidenmetyl)-1H-indol-2-karboksylsyre |
BG103779A BG103779A (en) | 1997-03-05 | 1999-10-04 | Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9704498D0 true GB9704498D0 (en) | 1997-04-23 |
Family
ID=10808697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9704498.6A Pending GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0966463A1 (et) |
JP (1) | JP2001513796A (et) |
KR (1) | KR20000075907A (et) |
CN (1) | CN1249750A (et) |
AP (1) | AP9901637A0 (et) |
AR (1) | AR011178A1 (et) |
AU (1) | AU6825198A (et) |
BG (1) | BG103779A (et) |
BR (1) | BR9808305A (et) |
CA (1) | CA2282851A1 (et) |
CO (1) | CO4940415A1 (et) |
EA (1) | EA199900710A1 (et) |
EE (1) | EE9900387A (et) |
GB (1) | GB9704498D0 (et) |
HR (1) | HRP980114A2 (et) |
HU (1) | HUP0002109A2 (et) |
ID (1) | ID24207A (et) |
IL (1) | IL131489A0 (et) |
IS (1) | IS5166A (et) |
NO (1) | NO994303L (et) |
NZ (1) | NZ337315A (et) |
OA (1) | OA11154A (et) |
PE (1) | PE51399A1 (et) |
PL (1) | PL335652A1 (et) |
SK (1) | SK119699A3 (et) |
TR (1) | TR199902117T2 (et) |
WO (1) | WO1998039327A1 (et) |
YU (1) | YU43499A (et) |
ZA (1) | ZA981791B (et) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
RU2020100230A (ru) | 2017-06-12 | 2021-07-13 | Глитек Ллс. | Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 EE EEP199900387A patent/EE9900387A/et unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PE51399A1 (es) | 1999-06-07 |
IL131489A0 (en) | 2001-01-28 |
NO994303L (no) | 1999-11-03 |
EA199900710A1 (ru) | 2000-04-24 |
BR9808305A (pt) | 2000-05-16 |
EE9900387A (et) | 2000-04-17 |
ID24207A (id) | 2000-07-13 |
HUP0002109A2 (hu) | 2001-04-28 |
SK119699A3 (en) | 2000-05-16 |
IS5166A (is) | 1999-08-27 |
PL335652A1 (en) | 2000-05-08 |
TR199902117T2 (xx) | 2000-03-21 |
AU6825198A (en) | 1998-09-22 |
OA11154A (en) | 2003-04-16 |
CN1249750A (zh) | 2000-04-05 |
NZ337315A (en) | 2001-02-23 |
BG103779A (en) | 2000-06-30 |
HRP980114A2 (en) | 1998-12-31 |
JP2001513796A (ja) | 2001-09-04 |
KR20000075907A (ko) | 2000-12-26 |
EP0966463A1 (en) | 1999-12-29 |
NO994303D0 (no) | 1999-09-03 |
CO4940415A1 (es) | 2000-07-24 |
AP9901637A0 (en) | 1999-09-30 |
ZA981791B (en) | 1999-09-03 |
CA2282851A1 (en) | 1998-09-11 |
WO1998039327A1 (en) | 1998-09-11 |
AR011178A1 (es) | 2000-08-02 |
YU43499A (sh) | 2000-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9705361D0 (en) | Chemical compounds | |
GB9704208D0 (en) | Chemical compounds | |
GB9708530D0 (en) | Chemical compounds | |
GB9708119D0 (en) | Chemical compounds | |
GB9703201D0 (en) | Chemical compounds | |
GB9704498D0 (en) | Chemical compound | |
GB9705212D0 (en) | Chemical compounds | |
GB9706707D0 (en) | Chemical compounds | |
GB9711994D0 (en) | Chemical compounds | |
GB9715768D0 (en) | Chemical compounds | |
GB9703350D0 (en) | Chemical compound | |
GB9725602D0 (en) | Chemical compound | |
GB9719002D0 (en) | Chemical compound | |
GB9705796D0 (en) | Chemical compound | |
GB9707452D0 (en) | Chemical compounds | |
GB9711708D0 (en) | Chemical compounds | |
GB9704223D0 (en) | Chemical compounds | |
GB9704224D0 (en) | Chemical compounds | |
GB9704809D0 (en) | Chemical compounds | |
GB9704151D0 (en) | Chemical compounds | |
GB9703200D0 (en) | Chemical compounds | |
GB9705830D0 (en) | Chemical compounds | |
GB9706668D0 (en) | Chemical compounds | |
GB9703136D0 (en) | Chemical compounds | |
GB9703027D0 (en) | Chemical compounds |